iX Biopharma Ltd. showcased its groundbreaking NAD (nicotinamide adenine dinucleotide) wafers at the prestigious Centre for Healthy Longevity Conference 2024 held in Singapore on 29 February to 1 March 2024. This event, which focused on the role of supplements in unlocking healthy longevity, brought together an esteemed cohort of leading scientists, including Professors Andrea Maier and Brian Kennedy of the NUHS Centre for Healthy Longevity, and Professor David Sinclair of the Harvard Medical School. Other expert clinicians, key opinion leaders, industry partners, consumer representatives, and regulatory authorities deeply involved in longevity and healthspan research were also present.

At the conference, iX Biopharma introduced its pioneering sublingual NAD wafers, leveraging the revolutionary NADiX technology to deliver pure NAD nanoparticles directly into the body without the need for otherwise invasive intravenous infusions. The feedback from the experts and participants was overwhelmingly positive, with many expressing excitement at NADiX being able to overcome challenges in delivering NAD to the body and the potential for the sublingual NAD wafers to be a game-changer in improving healthspan. The Company's showcase is timely and coincides with the announcement made by the State Council of the People's Republic of China ("PRC") in January 2024, in which the PRC government called on companies to better cater to the elderly and to promote the "silver economy" through measures including health products.

The Company intends to engage with potential partners and stakeholders in China and to that end, it will be exhibiting at the Wuhan Health Expo in April 2024, where an anticipated 300,000 participants will be attending.